# Olympia Women's Health – FDA 483, Jun 30, 2026

Source: https://www.keypedia.com/records/483/olympia-womens-health/c08ac0ad-15bc-4d41-a9ca-294924c4251c

> FDA 483 for Olympia Women's Health on June 30, 2026. Product: biologics. Access full analysis and detailed observations.

---

## Details

- Record Type: 483
- Company Name: Olympia Women's Health
- Inspection Date: 2026-06-30
- Product Type: biologics
- Office Name: Seattle District Office
- Summary: An FDA inspection of Olympia Women's Health in Olympia, WA, a human reproductive tissue establishment, identified a significant issue regarding donor eligibility. The firm failed to collect donor specimens for communicable disease testing at the appropriate time relative to oocyte retrieval for directed donors. This indicates a potential risk to tissue safety and compliance with regulations for human cells, tissues, and cellular and tissue-based products (HCT/Ps).

## Related Officers

- [issuing_officer](https://www.keypedia.com/people/sunitha-k-rajaram/1a0872d4-5e7b-4690-a2be-3877aec25053)

Company: https://www.keypedia.com/companies/olympia-womens-health/cb1c4830-e64d-4430-a543-229331fab691

Office: https://www.keypedia.com/offices/seattle-district-office/9305837f-0738-4075-b444-a55e7a2b8913